BALDUZZI, Sara
 Distribuzione geografica
Continente #
NA - Nord America 5.793
EU - Europa 2.703
AS - Asia 2.525
SA - Sud America 391
Continente sconosciuto - Info sul continente non disponibili 83
AF - Africa 67
OC - Oceania 6
Totale 11.568
Nazione #
US - Stati Uniti d'America 5.649
GB - Regno Unito 890
SG - Singapore 767
CN - Cina 570
IT - Italia 539
HK - Hong Kong 311
BR - Brasile 302
VN - Vietnam 299
SE - Svezia 261
DE - Germania 214
IE - Irlanda 155
BD - Bangladesh 153
FI - Finlandia 121
FR - Francia 105
RU - Federazione Russa 97
UA - Ucraina 85
CA - Canada 79
IN - India 69
KR - Corea 66
ID - Indonesia 52
TR - Turchia 52
NL - Olanda 41
BG - Bulgaria 35
MX - Messico 35
AR - Argentina 34
JP - Giappone 32
BE - Belgio 24
PL - Polonia 22
ZA - Sudafrica 22
PK - Pakistan 18
ES - Italia 16
AT - Austria 15
IQ - Iraq 15
CL - Cile 14
PH - Filippine 14
AE - Emirati Arabi Uniti 12
EC - Ecuador 12
GR - Grecia 12
MY - Malesia 12
LT - Lituania 11
CO - Colombia 9
JO - Giordania 9
MK - Macedonia 9
UZ - Uzbekistan 9
CR - Costa Rica 8
CZ - Repubblica Ceca 8
KE - Kenya 8
MA - Marocco 8
NP - Nepal 8
CH - Svizzera 7
IL - Israele 7
TH - Thailandia 7
VE - Venezuela 7
AU - Australia 6
BH - Bahrain 5
CY - Cipro 5
DK - Danimarca 5
DZ - Algeria 5
IR - Iran 5
JM - Giamaica 5
OM - Oman 5
PY - Paraguay 5
RO - Romania 5
TN - Tunisia 5
BO - Bolivia 4
MD - Moldavia 4
SA - Arabia Saudita 4
DO - Repubblica Dominicana 3
EE - Estonia 3
EG - Egitto 3
ET - Etiopia 3
NO - Norvegia 3
PE - Perù 3
SN - Senegal 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AZ - Azerbaigian 2
BB - Barbados 2
BN - Brunei Darussalam 2
BW - Botswana 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
LV - Lettonia 2
LY - Libia 2
PA - Panama 2
PT - Portogallo 2
RS - Serbia 2
TW - Taiwan 2
AD - Andorra 1
AM - Armenia 1
AP - ???statistics.table.value.countryCode.AP??? 1
BS - Bahamas 1
BY - Bielorussia 1
BZ - Belize 1
EU - Europa 1
GE - Georgia 1
GP - Guadalupe 1
HN - Honduras 1
HU - Ungheria 1
Totale 11.467
Città #
Southend 640
Ashburn 589
Fairfield 566
Singapore 521
Santa Clara 499
Woodbridge 320
Hong Kong 303
Chandler 302
San Jose 228
Houston 224
Seattle 206
Ann Arbor 185
Beijing 163
Wilmington 163
Dearborn 158
Dublin 154
Cambridge 151
Nyköping 143
Council Bluffs 120
Jacksonville 118
London 103
New York 102
Hefei 94
Hanoi 92
The Dalles 89
Helsinki 85
Ho Chi Minh City 83
Chicago 77
Los Angeles 77
Modena 74
Dallas 54
San Diego 51
Milan 49
Seoul 48
Bologna 40
Jakarta 39
Shanghai 39
Munich 37
Lauterbourg 36
Boardman 35
Moscow 34
Princeton 34
Sofia 33
São Paulo 33
Eugene 31
Buffalo 27
Rome 27
Columbus 26
Redwood City 26
Phoenix 25
Salt Lake City 23
Toronto 23
Frankfurt am Main 22
Izmir 21
Brussels 20
Bremen 19
Turin 19
Warsaw 19
Fremont 18
Montreal 18
Orem 18
Tokyo 18
San Francisco 17
Mexico City 16
Atlanta 14
Elk Grove Village 14
Dong Ket 13
Norwalk 13
Tampa 13
Brooklyn 12
Haiphong 11
Ottawa 10
Paris 10
Redondo Beach 10
Reggio Emilia 10
Sterling 10
Chennai 9
Hillsboro 9
Seongnam 9
Turku 9
Cleveland 8
Da Nang 8
Istanbul 8
North Bergen 8
Rio de Janeiro 8
Tilburg 8
Amman 7
Amsterdam 7
Biên Hòa 7
Buenos Aires 7
Johannesburg 7
Lappeenranta 7
Louisville 7
Miami 7
Nagoya 7
Nanjing 7
Stockholm 7
Tashkent 7
Brasília 6
Changchun 6
Totale 7.944
Nome #
Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: A randomized noninferiority trial 492
Non-steroid agents for idiopathic pulmonary fibrosis 476
Indicators of Complex Care During the Consultation-Liaison Psychiatry Activity at the Transplant Center of the Policlinico Hospital, Modena 450
The impact of shift work on the psychological and physical health of nurses in a general hospital: a comparison between rotating night shifts and day shifts 418
9 weeks vs 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study. 416
Impact of time to surgery after neoadjuvant chemotherapy in operable breast cancer patients 397
Short-term and long-term effects of tibolone in postmenopausal women 391
Efficacy of a multiple-component and multifactorial personalized fall prevention program in a mixed population of community-dwelling older adults with stroke, Parkinson's Disease, or frailty compared to usual care: The PRE.C.I.S.A. randomized controlled trial 386
9 weeks vs 1 year adjuvant trastuzumab in combination with chemotherapy: Results of the phase III multicentric Italian study Short-HER 370
Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer. 363
Validation of the AJCC prognostic stage for HER2-positive breast cancer in the ShortHER trial . 358
Impact of body composition parameters on tumor response to neoadjuvant chemotherapy in operable breast cancer patients. 356
3* Final analysis of the phase III multicentric Italian study Short-HER: 9 weeks vs 1 year adjuvant trastuzumab for HER2+ early breast cancer 339
"the More the Better" Paradox of Antenatal Ultrasound Examinations in Low-Risk Pregnancy 339
Safety and efficacy of T-DM1 in HER2 positive metastatic breast cancer patients: a real word experience. 317
Home Oxygen Saturation Monitoring And Quality Of Life Evaluation In Patients With Idiopathic Pulmonary Fibrosis: Preliminary Results From A Prospective Multicenter Trial 300
Are the Two Human Papillomavirus Vaccines Really Similar? A Systematic Review of Available Evidence: Efficacy of the Two Vaccines against HPV 300
Trastuzumab containing regimens for early breast cancer. 299
Prevalence Of Subclinical Liver Fibrosis Among Patients With Idiopathic Pulmonary Fibrosis 298
Clinical differences in sarcoidosis patients with and without lymphoma: a single-center retrospective cohort analysis. 293
Systematic review of maternal voice interventions demonstrates increased stability in preterm infants 291
Predictive Role Of Body Composition Parameters In Operable Breast Cancer Patients Treated With Neoadjuvant Chemotherapy. 290
HRCT Patterns Of Usual Interstitial Pneumonia In Rheumatoid Lung 289
New approaches to the design of clinical trials in idiopathic pulmonary fibrosis 286
Quantiferon-TB Gold In-Tube Tests In Hospital Health Care Workers: A Five Years Experience 280
9 weeks versus 1 year adjuvant trastuzumab for HER2+ early breast cancer: Subgroup analysis of the ShortHER trial allows to identify patients for whom a shorter trastuzumab administration may have a favourable risk/benefit ratio 273
Impact of anaemia on tumor response to neoadjuvant chemotherapy in breast cancer patients . 272
Stereotactic Ablative Radiotherapy as an Alternative to Lobectomy in Patients With Medically Operable Stage I NSCLC: A Retrospective, Multicenter Analysis 271
Short and long term effects of tibolone in postmenopausal women 256
Effectiveness of support groups to improve the quality of life of people with idiopathic pulmonary fibrosis a pre-post test pilot study 247
Repeated Quantiferon-TB Gold In-Tube Tests In Routine Clinical Practice: A Five Years Experience 245
Trastuzumab-containing regimens for metastatic breast cancer 235
Pattern of distant relapse according to intrinsic molecular subtype in patients with HER2-positive breast cancer: a combined analysis of ShortHER, CherLOB, and two institutional cohorts 210
Metastatic site patterns by intrinsic subtype and HER2DX in early HER2-positive breast cancer 180
Erlotinib for advanced pancreatic cancer 180
Outpatient parents' views on shared-decision-making at an Italian children's hospital 161
Nine-Week Versus One-Year Trastuzumab for Early Human Epidermal Growth Factor Receptor 2â € "Positive Breast Cancer: 10-Year Update of the ShortHER Phase III Randomized Trial 150
Interaction between tumor-infiltrating lymphocytes and BMI in early HER2-positive breast cancer: analysis of the ShortHER trial. 56
Tumor-Infiltrating Lymphocytes and Survival Outcomes in Early ERBB2-Positive Breast Cancer: 10-Year Analysis of the ShortHER Randomized Clinical Trial. 38
Totale 11.568
Categoria #
all - tutte 41.247
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.247


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022755 0 47 92 43 26 49 32 55 89 80 153 89
2022/2023996 93 119 71 90 91 97 26 93 241 13 18 44
2023/2024612 21 27 44 53 103 58 78 60 23 39 43 63
2024/20251.826 57 25 38 108 363 316 147 116 168 73 174 241
2025/20263.678 232 99 246 338 587 241 514 197 359 385 307 173
2026/2027185 166 19 0 0 0 0 0 0 0 0 0 0
Totale 11.568